Anlotinib + Epirubicin (neoadjuvant)
NAET4-SNACC
Eye and ENT Hospital of Fudan University · Phase 2 · Recruiting · Enrollment 76
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
Anlotinib + Epirubicin (neoadjuvant)
Eye and ENT Hospital of Fudan University · Phase 2 · Recruiting · Enrollment 76
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.